These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 115305)
1. Renin, aldosterone and cardiac decompensation: studies with an oral converting enzyme inhibitor in heart failure. Tarazi RC; Fouad FM; Ceimo JK; Bravo EL Am J Cardiol; 1979 Oct; 44(5):1013-8. PubMed ID: 115305 [No Abstract] [Full Text] [Related]
2. Clinical use of an orally acting converting enzyme inhibitor: captopril. Brunner HR; Gavras H; Waeber B; Textor SC; Turini GA; Wauters JP Hypertension; 1980; 2(4):558-66. PubMed ID: 6995296 [No Abstract] [Full Text] [Related]
3. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure. Levine TB; Franciosa JA; Cohn JN Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102 [No Abstract] [Full Text] [Related]
4. Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure. Dahlström U; Karlberg BE Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):231S-235S. PubMed ID: 6753905 [TBL] [Abstract][Full Text] [Related]
5. Long-term control of congestive heart failure with captopril. Fouad FM; Tarazi RC; Bravo EL; Hart NJ; Castle LW; Salcedo EE Am J Cardiol; 1982 Apr; 49(6):1489-96. PubMed ID: 6803563 [TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril. Turini GA; Waeber B; Brunner HR Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835 [TBL] [Abstract][Full Text] [Related]
7. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone. Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940 [TBL] [Abstract][Full Text] [Related]
8. Captopril - an oral angiotensin-converting enzyme inhibitor in CHF. Chatterjee K; Rouleau JL; Parmley WW Acta Med Scand Suppl; 1981; 652():181-7. PubMed ID: 6800218 [No Abstract] [Full Text] [Related]
9. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies. Nicholls MG; Ikram H; Espiner EA; Maslowski AH; Scandrett MS; Penman T Am J Cardiol; 1982 Apr; 49(6):1497-501. PubMed ID: 6803564 [TBL] [Abstract][Full Text] [Related]
10. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)]. Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526 [No Abstract] [Full Text] [Related]
11. Long-term treatment of congestive heart failure with captopril. Komajda M; Eugene M; Evans J; Drobinski G; Laurenceau JL; Grosgogeat Y Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):223S-229S. PubMed ID: 6753904 [TBL] [Abstract][Full Text] [Related]
12. Acute and chronic effects of captopril therapy in patients with refractory heart failure. Walsh WF; Lee CL Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):153S-159S. PubMed ID: 6753896 [No Abstract] [Full Text] [Related]
13. Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure. Cody RJ; Franklin KW; Laragh JH Am Heart J; 1982 Apr; 103(4 Pt 1):480-4. PubMed ID: 7039281 [TBL] [Abstract][Full Text] [Related]
14. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension. Sassano P; Pedrinelli R; Magagna A; Abdel-Haq B; Salvetti A Am J Cardiol; 1982 Apr; 49(6):1574-6. PubMed ID: 6280486 [TBL] [Abstract][Full Text] [Related]
15. Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects. Sharpe DN; Coxon R Aust N Z J Med; 1982 Oct; 12(5):483-8. PubMed ID: 6758746 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of captopril in patients with severe chronic heart failure. LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587 [TBL] [Abstract][Full Text] [Related]
17. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure. Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564 [TBL] [Abstract][Full Text] [Related]
18. Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages. Pacher R; Globits S; Bergler-Klein J; Teufelsbauer H; Wutte M; Baumgartner W; Ogris E; Glogar D Eur Heart J; 1993 Feb; 14(2):273-8. PubMed ID: 8449205 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure. Cleland J; Semple P; Hodsman P; Ball S; Ford I; Dargie H Am J Med; 1984 Nov; 77(5):880-6. PubMed ID: 6388325 [TBL] [Abstract][Full Text] [Related]
20. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]